Evidence map›Paper›PMID 32133259›Full record

ArticleCureus2020

Leptin Signaling in Liver Tissue of a Transgenic Breast Cancer Mouse Model.

Bilge Guvenc Tuna, Margot P Cleary, Pinar B Demirel, Soner Dogan

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Bilge Guvenc TunaBiophysics, Yeditepe University Faculty of Medicine, İstanbul, TUR.
Margot P ClearyFood Science and Nutrition, University of Minnesota Hormel Institute, Austin, USA.
Pinar B DemirelMedical Biology and Genetics, Maltepe University Facullty of Medicine, Istanbul, TUR.
Soner DoganMedical Biology, Yeditepe University School of Medicine, Istanbul, TUR.
Hormel (United States) · USYeditepe University · TR

Funding

Intermittent food restriction prevents mammary tumorsR01CA101858 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI CLEARY, MARGOT P · 2004 to 2008
$1.3M
NCI NIH HHS R01 CA101858
6 · The paper itself

Abstract

Leptin, an adipocytokine, is secreted from various tissues including the liver. The roles of both leptin and leptin receptor (ObR) in numerous pathophysiological conditions including mammary tumor (MT) development have been reported. However, the roles of leptin signaling-related proteins in the liver have not been reported previously in MT development. The objective of this study was to examine the expression levels of leptin and ObR in liver tissue of a transgenic breast cancer mouse model to investigate whether the roles of leptin in MT development are systemic or local. MMTV-TGF-α transgenic female mice were fed ad-libitum from week 10 up to week 74. Protein expression levels of leptin and ObR were measured in liver tissues of 74-week-old MMTV-TGF-α mice with and without MT by western blot. Serum leptin and insulin levels were measured using a enzyme-linked immunosorbent assay. Protein expression levels of leptin and ObR were similar in mice with MT compared to the ones without MT. Serum leptin and insulin levels were also not significantly different between the two groups. These results indicate that the effects of leptin signaling in MT development might be important at a local tissue level, such as mammary fat pad, and not as important at a systemic level.

Indexed as

breast cancerleptinleptin receptorlivermammary tumortransgenic mouse model

Identifiers

PMID32133259
PMCPMC7034766
OpenAlexW3001053589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.